PWM
BIIB icon

Parkworth Wealth Management’s Biogen BIIB Stock Holding History

Parkworth Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$754 Buy
+6
New +$748 ﹤0.01% 495
2025
Q1 		– Sell
-1
Closed -$153 – 1235
2024
Q4 		$153 Buy
+1
New +$169 ﹤0.01% 846

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parkworth Wealth Management's BIIB Position: Q2 2025 in Review

Parkworth Wealth Management opened a new position in Biogen (BIIB) in Q2 2025: 6 shares worth $754. The stake represents ﹤0.01% of the portfolio and ranks #495 among its holdings. This is a return to the name: Parkworth Wealth Management previously reported a position in BIIB as recently as Q4 2024.

Parkworth Wealth Management first reported a position in BIIB in Q4 2024 and has held it in 2 quarters since. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Parkworth Wealth Management held 6 shares of Biogen worth $754 as of Q2 2025.
  • Biogen was a new Parkworth Wealth Management position in Q2 2025.
  • Biogen made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #495 holding.
  • Parkworth Wealth Management first reported a position in Biogen in Q4 2024 and has held it in 2 quarters since.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.